Digital pathology evaluations have a tendency to expand rather than narrow as they progress. What begins as a focused discussion about new technology quickly evolves into parallel conversations about diagnostic quality, workflow impact, infrastructure requirements, and capital planning.
Clinical leaders prioritize diagnostic confidence and subspecialty depth. Operations leaders focus on throughput and case distribution. IT evaluates security, integration, and system resilience. Executive leadership weighs financial exposure and timing. Each perspective is valid. The challenge is that these priorities are often explored independently rather than aligned around a shared definition of success.
The most effective organizations address this early by answering a single clarifying question: What must be true 6 months, and 12 months after implementation for this initiative to be considered successful? With shared success criteria in place, alignment replaces ambiguity. Discussions that once circled around competing definitions of value begin to converge around execution. Integration requirements are prioritized based on their impact, ROI becomes measurable rather than aspirational, and vendor comparisons are grounded in defined operational outcomes. The evaluation no longer expands, it advances.
Alignment is not a soft concept. It determines whether an evaluation gains momentum or stalls. Without shared success criteria, discussions revisit the same questions, timelines extend, and implementation becomes harder to commit to.
We explore how misalignment contributes to stalled digital pathology initiatives, and how leading labs establish shared success criteria before evaluation complexity sets in, in our full analysis, Digital Pathology Adoption Challenges: A Practical Guide for Pathologists and Lab Directors.
